Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?

被引：0
|
作者：
Chris Skedgel
Daniel Rayson
Tallal Younis
机构：
[1] University of East Anglia,Norwich Medical School
[2] Capital Health,Atlantic Clinical Cancer Research Unit
[3] Capital Health,Department of Medicine
来源：
Supportive Care in Cancer | 2016年 / 24卷
关键词：
Breast cancer; Febrile neutropenia; Granulocyte colony-stimulating factors; Economic evaluation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：387 / 394
页数：7
相关论文
共 50 条
  • [31] Cost-Effectiveness of Granulocyte Colony-Stimulating Factor Prophylaxis for Febrile Neutropenia in Breast Cancer in the United Kingdom
    Whyte, Sophie
    Cooper, Katy L.
    Stevenson, Matt D.
    Madan, Jason
    Akehurst, Ron
    VALUE IN HEALTH, 2011, 14 (04) : 465 - 474
  • [32] Febrile neutropenia with adjuvant docetaxel and cyclophosphamide (TC) chemotherapy for breast cancer.
    Yu, Joanne Linda
    Kurin, Michael
    Pasetka, Mark
    Sridhar, Srikala S.
    Warner, Ellen
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [33] A multicenter study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of taxotere/cyclophosphamide-induced febrile neutropenia in patients with early-stage breast cancer.
    Clemons, Mark J.
    Fergusson, Dean
    Joy, Anil A.
    Meza-Junco, Judith
    Hiller, Julie A. Price
    Mackey, John Robert
    Zhu, Xiaofu
    Ibrahim, Mohammed Fk
    Basulaiman, Bassam Mohammed
    Awan, Arif Ali
    Sienkiewicz, Marta
    Vandermeer, Lisa
    Pitre, Lacey D.
    Nixon, Nancy Alice
    Hutton, Brian
    Pond, Gregory Russell
    Hilton, John Frederick
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors
    Kelly, S.
    Wheatley, D.
    BRITISH JOURNAL OF CANCER, 2009, 101 : S6 - S10
  • [35] A multi-centre study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of docetaxel-cyclophosphamide induced febrile neutropenia
    Clemons, Mark
    Fergusson, Dean
    Joy, Anil A.
    Thavorn, Kednapa
    Meza-Junco, Judith
    Hiller, Julie Price
    Mackey, John
    Ng, Terry
    Zhu, Xiaofu
    Ibrahim, Mohammed F. K.
    Sienkiewicz, Marta
    Saunders, Deanna
    Vandermeer, Lisa
    Pond, Gregory
    Basulaiman, Bassam
    Awan, Arif
    Pitre, Lacey
    Nixon, Nancy A.
    Hutton, Brian
    Hilton, John F.
    BREAST, 2021, 58 : 42 - 49
  • [36] Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors
    S Kelly
    D Wheatley
    British Journal of Cancer, 2009, 101 : S6 - S10
  • [37] Current practice of prophylaxis with granulocyte colony-stimulating factors for preventing chemotherapy-induced neutropenia in breast cancer patients in Spain
    Marina, J.
    Carabantes, F. J.
    de Romani, S. Escriva
    Pernas, S.
    Cantos, B.
    Caranana, V.
    Llorca, C.
    Vazquez, F.
    Ciruelos, E.
    Menjon, S.
    EJC SUPPLEMENTS, 2009, 7 (02): : 181 - 181
  • [38] Utilization of Granulocyte Colony Stimulating Factors in chemotherapy induced neutropenia in patients with breast or lung cancer:: Portugal
    Félix, J.
    Ferreira, J. M.
    Borrego, P.
    Duarte-Ramos, F.
    Andreozzi, V.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S166 - S167
  • [39] Preventing healthcare-acquired infections in cancer patients with febrile neutropenia in intensive care units: The role of granulocyte-colony stimulating factor prophylaxis
    Chou, Hui-Chen
    Tsai, Yin-Shin
    Wang, Yu-Ting
    Shueng, Pei-Wei
    Hsu, Chen-Xiong
    INTENSIVE AND CRITICAL CARE NURSING, 2023, 78
  • [40] Preventing healthcare-acquired infections in cancer patients with febrile neutropenia in intensive care units: The role of granulocyte-colony stimulating factor prophylaxis
    Blot, Stijn
    Timsit, Jean-Francois
    Zahar, Jean-Ralph
    INTENSIVE AND CRITICAL CARE NURSING, 2023, 78
12345